ALLOPURİNOL KULLANIMI SONRASINDA GELİŞEN DRESS SENDROMU; OLGU SUNUMU

Abstract

Allopurinolün indüklediği DRESS sendromu eozinofili ve sistemik semptomlarla karakterize hayatı tehdit edici bir ilaç reaksiyonudur. Bu olgu sunumunda 20 günlük allopurinol tedavisi sonrasında makülopapüler döküntü ve sistemik semptomlar ile DRESS tanısı alan 72 yaşında bir kadın hasta sunuldu

Keywords

• allopurinol,DRESS sendromu,tedavi

DRESS SYNDROME AFTER ALLOPURINOL TREATMENT; A CASE REPORT

Abstract

DRESS syndrome which is induced by allopurinol is a medical reaction threatining the life characterized with eosinophilia and systemic symptoms. In this case presentation, after allopurinol treatment for 20 days, a 72 years-old ill woman who has maculopapular rash and systematic symptoms with DRESS syndrome was presented

Keywords

• allopurinol,DRESS syndrome,treatment

References

1. ) Walsh SA, Creamer D: Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 2010; 36(1): 11.
2. ) Cacoub P, Musette P, Descamps V, et al: The DRESS syndrome: A literature review. Am J Med 2011; 124(7): 97.
3. ) Michel F, Navellou JC, Ferraud D, et al. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Joint Bone Spine 2005; 72(1): 82-5.
4. ) Hassan S, Wetz R, Zouein E. Allopurinol causing drug rash with eosinophilia and systemic symptoms syndrome: a challenging diagnosis. Int J Gen Med 2011;4:789-92.
5. ) Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al: Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156(3): 609
6. ) Ferahbaş A, Özyurt K. Antikonvülzan hipersensitivite sendromu. Erciyes Tıp Dergisi 2002;24:107-11.
7. ) Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 1986; 29(1): 82-7.
8. ) Walsh S, Diaz-Cano S, Higgins E, et al: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol 2012 doi: 10.1111/bjd.12081.

9. ) Criado PR, Criado RFJ, Avancini JM, Santi CG: Drug reaction with eosinophilia and systemic symptoms (DRESS)/ drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An Bras Dermatol 2012; (3): 435-49.
10. ) Shalom R, Rimbroth S, Rozenman D, et al. Allopurinol- induced recurrent DRESS syndrome: pathophysiology and treatment. Ren Fail 2008; 30(3): 327-9.
11. ) Chiou CC, Yang LC, Hung SI, et al: Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dedmatol Verenol 2008; 22(9): 1044-9.
12. ) Chen YC, Chiu HC, Chu CY: Drug Reaction With Eosinophilia and Systemic Symptoms:A Retrospective Study of 60 Cases. Arch Dermatol 2010; 146(1): 1373-9.
13. ) Cacaub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS sendrome; a literature review Am J Med. 2011; 124 (7):588.
14. ) Criado PR, Avancini J, Santi CG, et al: Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. Isr Med Assoc J 2012; 14(9):577-82.